Speech acoustic markers of early stage and prodromal Huntington's disease: A marker of disease onset?

Neuropsychologia

Volumn 50, Issue 14, 2012, Pages 3273-3278

  Vogel, Adam P ^a   Shirbin, Christopher ^b   Churchyard, Andrew J ^b   Stout, Julie C ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Clinical marker; Huntington's disease; Prodomal; Speech

Indexed keywords

ACOUSTIC ANALYSIS; ACOUSTICS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; GENE; GENE MUTATION; HTT GENE; HUMAN; HUNTINGTON CHOREA; MALE; RATING SCALE; READING; SCORING SYSTEM; SPEECH; STIMULUS RESPONSE; TASK PERFORMANCE; UNITED HUNTINGTON DISEASE RATING SCALE;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; REACTION TIME; SPEECH; SPEECH ACOUSTICS; TIME FACTORS;

EID: 84868304824     PISSN: 00283932     EISSN: 18733514     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2012.09.011     Document Type: Article

References (40)

1. Artkoski M., Tommila J., Laukkanen A.M. Changes in voice during a day in normal voices without vocal loading. Logopedics Phoniatrics Vocology 2002, 27:118-123.
2. Backman L., Robins-Wahlin T.B., Lundin A., Ginovart N., Farde L. Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes. Brain 1997, 120:2207-2217.
3. Bechtel N., Scahill R.I., Rosas H.D., Acharya T., van den Bogaard S.J.A., Jauffret C., et al. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology 2010, 75:2150-2160.
4. Boersma, P., & Weenink, D. (2011). PRAAT: Doing phonetics by computer. In (5.2.38 ed.). Amsterdam.
5. Bohanna I., Georgiou-Karistianis N., Egan G.F. Connectivity-based segmentation of the striatum in Huntington's disease: Vulnerability of motor pathways. Neurobiology of Disease 2011, 42:475-481.
6. Bohanna I., Georgiou-Karistianis N., Sritharan A., Asadi H., Johnston L., Churchyard A., et al. Diffusion Tensor Imaging in Huntington's disease reveals distinct patterns of white matter degeneration associated with motor and cognitive deficits. Brain Imaging and Behavior 2011, 5:171-180.
7. Coleman R., Anderson D., Lovrien E. Oral motor dysfunction in individuals at risk of Huntington disease. American Journal of Medical Genetics 1990, 37:36.
8. Duff K., Paulsen J.S., Beglinger L.J., Langbehn D.R., Stout J.C. Psychiatric Symptoms in Huntington's Disease before Diagnosis: The Predict-HD Study. Biological Psychiatry 2007, 62:1341-1346.
9. Folker J.E., Murdoch B.E., Cahill L.M., Delatycki M.B., Corben L.A., Vogel A.P. Dysarthria in Friedreich's ataxia: a perceptual analysis. Folia Phoniatrica et Logopaedia 2010, 62:97-103.
10. Gordon W.P., Illes J. Neurolinguistic characteristics of language production in Huntington's disease: a preliminary report. Brain & Language 1987, 31:1.
11. Harel B.T., Cannizzaro M.S., Cohen H., Reilly N., Snyder P.J. Acoustic characteristics of Parkinsonian speech: a potential biomarker of early disease progression and treatment. Journal of Neurolinguistics 2004, 17:439-453.
12. Hartelius L., Carlstedt A., Ytterberg M., Lillvik M., Laakso K. Speech disorders in mild and moderate Huntington disease: results of dysarthria assessments of 19 individuals. Journal of Medical Speech-Language Pathology 2003, 11(14):1.
13. Hertrich I., Ackermann H. Acoustic analysis of speech timing in Huntington's disease. Brain & Language 1994, 47:182-196.
14. Ho A.K., Sahakian B.J., Brown R.G., Barker R.A., Hodges J.R., Ane M.N., et al. Profile of cognitive progression in early Huntington's disease. Neurology 2003, 61:1702-1706.
15. Kipps C.M., Duggins A.J., Mahant N., Gomes L., Ashburner J., McCusker E.A. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. Journal of Neurology, Neurosurgery & Psychiatry 2005, 76:650-655.
16. Kluin K.J., Gilman S., Foster N.L., Sima A.A.F., D'Amato C.J., Bruch L.A., et al. Neuropathological correlates of Dysarthria in progressive supranuclear palsy. Archives of Neurology 2001, 58:265-269.
17. Kremer B., Goldberg P., Andrew S.E., Theilmann J., Telenius H., Zeisler J., et al. A Worldwide Study of the Huntington's Disease Mutation: The sensitivity and specificity of measuring CAG Repeats. New England Journal of Medicine 1994, 330:1401-1406.
18. MacDonald M.E., Ambrose C.M., Duyao M.P., Myers R.H., Lin C., Srinidhi L., et al. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
19. Mundt J.C., Vogel A.P., Feltner D.E., Lenderking W.R. Vocal Acoustic Biomarkers of Depression Severity and Treatment Response. Biological Psychiatry 2012, 72:580-587.
20. Murdoch B.E. Surgical approaches to treatment of Parkinson's disease: Implications for speech function. International Journal of Speech-Language Pathology 2010, 12:375-384.
21. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. Journal of Neurology, Neurosurgery & Psychiatry 2008, 79:874-880.
22. Penney J.B., Vonsattel J.-P., Macdonald M.E., Gusella J.F., Myers R.H. CAG repeat number governs the development rate of pathology in Huntington's disease. Annals of Neurology 1997, 41:689-692.
23. Quinn N., Schrag A. Huntington's disease and other choreas. Journal of Neurology 1998, 245:709. (708).
24. Rosen K.M., Murdoch B.E., Folker J.E., Vogel A.P., Cahill L., Delatycki M., et al. Automatic method of pause measurement for normal and dysarthric speech. Clinical Linguistics & Phonetics 2010, 24:141-154.
25. Saldert C., Fors A., Ströberg S., Hartelius L. Comprehension of complex discourse in different stages of Huntington's disease. International Journal of Language & Communication Disorders 2010, 45:656-669.
26. Squitieri F., Berardelli A., Nargi E., Castellotti B., Mariotti C., Cannella M., et al. Atypical movement disorders in the early stages of Huntingtons disease: clinical and genetic analysis. Clinical Genetics 2000, 58:50-56.
27. Squitieri F., Cannella M., Giallonardo P., Maglione V., Mariotti C., Hayden M.R. Onset and pre-onset studies to define the Huntington's disease natural history. Brain Research Bulletin 2001, 56:233.
28. Stout J.C., Paulsen J.S., Queller S., Solomon A.C., Whitlock K.B., Campbell J.C., et al. Neurocognitive signs in prodromal Huntington disease. Neuropsychology 2011, 25:1-14.
29. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. The Lancet Neurology 2009, 8:791-801.
30. Tabrizi S.J., Reilmann R., Roos R.A.C., Durr A., Leavitt B.R., Owen G., et al. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data. The Lancet Neurology 2012, 11:42-53.
31. Tabrizi S.J., Scahill R.I., Durr A., Roos R.A., Leavitt B.R., Jones R., et al. Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis. The Lancet Neurology 2011, 10:31-42.
32. Thompson J.C., Snowden J.S., Craufurd D., Neary D. Behavior in Huntington's Disease: Dissociating Cognition-Based and Mood-Based Changes. Journal of Neuropsychiatry & Clinical Neurosciences 2002, 14:37-43.
33. Tsanas A., Little M.A., McSharry P.E., Ramig L.O. Nonlinear speech analysis algorithms mapped to a standard metric achieve clinically useful quantification of average Parkinson's disease symptom severity. Journal of The Royal Society Interface 2011, 8:842-855.
34. Unified Huntington's Disease Rating Scale: reliability and consistency.Huntington Study Group Movement Disorders 1996, 11:136-142.
35. van Beers R.J., Baraduc P., Wolpert D.M. Role of uncertainty in sensorimotor control. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences 2002, 357:1137-1145.
36. Vassos E., Panas M., Kladi A., Vassilopoulos D. Effect of CAG repeat length on psychiatric disorders in Huntington's disease. Journal of Psychiatric Research 2008, 42:544-549.
37. Vogel A.P., Fletcher J., Maruff P. Acoustic analysis of the effect of sustained wakefulness on speech. Journal of the Acoustical Society of America 2010, 128:3747-3756.
38. Vogel A.P., Fletcher J., Snyder P.J., Fredrickson A., Maruff P. Reliability, Stability, and Sensitivity to Change and Impairment in Acoustic Measures of Timing and Frequency. Journal of Voice 2011, 25:137-149.
39. Vogel A.P., Maruff P. Comparison of voice acquisition methodologies in speech research. Behavior Research Methods 2008, 40:982-987.
40. Vogel A.P., Maruff P., Snyder P.J., Mundt J.C. Standardization of pitch range settings in voice acoustic analysis. Behavior Research Methods 2009, 41:318-324.